Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases

Cellular and Molecular Immunology

Volumn 8, Issue 1, 2011, Pages 19-22

  Lin, Hu ^a   Xu, Ruonan ^a   Zhang, Zheng ^a   Chen, Liming ^a   Shi, Ming ^a   Wang, Fu Sheng ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

immunomodulation; liver diseases; mesenchymal stem cells; transplantation

Indexed keywords

APOPTOSIS; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CYTOKINE PRODUCTION; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; LIVER CELL; LIVER DISEASE; LIVER FAILURE; LIVER FIBROSIS; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLIC DISORDER; MIGRATION INHIBITION; MITOSIS INHIBITION; NONHUMAN; PATIENT SAFETY; REVIEW; SIGNAL TRANSDUCTION; THERAPY EFFECT;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; HUMANS; IMMUNOMODULATION; LIVER; LIVER DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; RATS; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

ANIMALIA;

EID: 79952460157     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.57     Document Type: Review

References (40)

1. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. Pluripotency of mesenchymal stem cells drived from adult marrow. Nature 2002; 418: 41-49. (Pubitemid 34742565)
2. Deng X, Chen YX, Zhang X, Zhang JP, Yin C, Yue HY et al. Hepatic stellate cells modulate the differentiation of bone marrow mesenchymal stem cells into hepatocyte-like cells. J Cell Physiol 2008; 217: 138-144.
3. Okuyama H, Krishnamachary B, Zhou YF, Nagasawa H, Bosch-Marce M, Semenza GL Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymalcells isdependentonhypoxia-induciblefactor. J Biol Chem 2006; 281: 15554-15563. (Pubitemid 43855148)
4. Aurich H, Sgodda M, Kaltwasser P, Vetter M, Weise A, Liehr T et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009; 58: 570-581.
5. Bonora-Centelles A, Jover R, Mirabet V, Lahoz A, Bonora-Centelles A,Carbonell Fet al. Sequential hepatogenic trans-differentiation of adipose tissue-derived stem cells: relevance of different extracellular signaling molecules, transcription factors involved and expression of new key marker genes. Cell Transplant 2009; 18: 1319-1340.
6. Campard D, Lysy PA, Najimi M, Sokal EM. Native umbilical cord matrixstem cells expresshepatic markersanddifferentiateintohepatocyte-likecells. Gastroenterology 2008; 134: 833-848. (Pubitemid 351312728)
7. Lange C, Bassler P, Lioznov MV, Bruns H, Kluth D, Zander AR et al. Liver-specificgene expression in mesenchymal stem cells is induced by liver cells. World J Gastroenterol 2005; 11: 4497-4504. (Pubitemid 41150389)
8. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitroand in vivo. Hepatology 2008; 47: 1634-1643. (Pubitemid 351702746)
9. Zhou P, Hohm S, Olusanya Y, Hess DA, Nolta J. Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model. Hepatology 2009; 49: 1992-2000.
10. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007; 104: 11002-11007. (Pubitemid 47175216)
11. Hematti P. Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev 2008; 22: 262-273.
12. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007; 2: e941.
13. Kiss J, Urbán VS, Dudics V, Vas V, Uher F. Mesenchymal stem cellsandthe immune system-immunosuppression without drugs? Orv Hetil 2008; 149: 339-346. (Pubitemid 351359162)
14. Yagi K, Kojima M, Oyagi S, Ikeda E, Hirose M, Isoda K et al. Application of mesenchymal stem cells to liver regenerative medicine. Yakugaku Zasshi 2008; 128: 3-9.
15. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M et al. IFATS collection: in vivotherapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008; 26: 2705-2712.
16. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Mohyeddin-Bonab M, Bagheri M, Bashtar M et al. Phase I trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated cirrhosis. Arch Iran Med 2007; 10: 459-466. (Pubitemid 350001896)
17. Tsai PC, Fu TW, Chen YM, Ko TL, Chen TH, Shih YH, et al. the Therapeuticpotential of human umbilical mesenchymal stem cellsfrom Wharton'sjellyin the Treatmentof rat liver fibrosis. Liver Transpl 2009; 15: 484-495.
18. Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S, Niioka M et al. Bonemarrow-derived cells express matrix metalloproteinases and contributeto regression of liver fibrosis in mice. Hepatology 2007; 45: 213-222. (Pubitemid 46144381)
19. Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem. Biophys Res Commun 2007; 363: 247-252. (Pubitemid 47484321)
20. Carvalho AB, Quintanilha LF, Dias JV, Paredes BD, Mannheimer EG, Carvalho FG et al. Bonemarrowmultipotentmesenchymalstromalcellsdonotreducefibrosisor improve function in a rat model of severe chronic liver injury. Stem Cells 2008; 26: 1307-1314.
21. Di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E et al. Human MSCs as a two-edged sword in hepatic regenerative medicine-engraftment and hepatocytes differentiation versus profibrogenic potential. Gut 2008; 57: 223-231. (Pubitemid 351158051)
22. Agnieszka B, Takumi T, Yusuke Y, Tokuhara M, Takeshita F, Osaki M et al. Rapid hepaticfatespecificationofadipose- derivedstemcellsandtheirtherapeuticpotential for liver failure. J Gastroenterol Hepatol 2009; 24: 70-77.
23. Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009; 21: 1199-1205.
24. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, et al. Stem cell therapyfor liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008; 134: 2111-2121.
25. Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins R,Tilles A et al. Long term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A 2009; 15: 3377-3388.
26. Khan AA, Parveen N, Mahaboob VS, Rajendraprasad A, Ravindraprakash HR, Venkateswarlu J et al. Treatment of Crigler-Najjar Syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia. Transplant Proc 2008; 40: 1148-1150. (Pubitemid 351794281)
27. Frossard V, Ketterer N, Rosselet A, Meier P, Cairoli A, Duchosal MA et al. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience. Ann Hematol 2009; 88: 681-685.
28. Miranda PS, Bosma PJ. Towards liver-directed gene therapy for Crigler-Najjar syndrome. Curr Gene Ther 2009; 9: 72-82.
29. Rubio D, Garcia-Castro J, Mart́n MC, de la Fuente R, Cigudosa JC, Lloyd AC et al. Spontaneous human adult stem cell transformation. Cancer Res 2005; 65: 3035-3039. (Pubitemid 40524580)
30. McBride C, Gaupp D, Phinney DG. Quantifying levels of transplanted murine and humanmesenchymalstemcells in vivobyreal-timePCR. Cytotherapy 2003; 5: 7-18. (Pubitemid 36382931)
31. Takeda M, Yamamoto M, Isoda K, Higashiyama S, Hirose M, Ohgushi H et al. Availability of bone marrow stromal cells in three-dimensional coculture with hepatocytes and transplantation into liver-damaged mice. J Biosci Bioeng 2005; 100: 77-81. (Pubitemid 41569349)
32. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant Proc 2007; 39: 573-576. (Pubitemid 46386222)
33. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007; 13: 3359-3363. (Pubitemid 47062247)
34. Xiang GA, Zhang GQ, Fang CH, Gao P, Chen KY. A preliminary study of the homing capacityof allograft mesenchymal stem cellsto rat liver. Di Yi Jun Yi Da Xue Xue Bao 2005; 25: 994-997.
35. Hashemi S, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected byendomyocardial delivery after an acute myocardial infarction. Eur Heart J 2008; 29: 251-259.
36. Kuhn NZ, Tuan RS. Regulationof stemnessandstem cell nicheof mesenchymalstem cells: implications in tumorigenesis and metastasis. J Cell Physiol 2010; 222: 268-277.
37. Lazennec G, Jorgensen C. Concisereview: adult multipotent stromal cells andcancer: risk or benefit? Stem cells 2008; 26: 1387-1394.
38. Ren G, Su J, Zhang L, Zhao X, Ling W, L'huillie A et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009; 27: 1954-1962.
39. Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal stromal cells. Ann NY Acad Sci 2009; 1176: 101-117.
40. Sundin M, Orvell C, Rasmusson I, Sundberg B, Ringdén O, Le Blanc K. Mesenchymal stem cellsaresusceptibleto human herpesviruses, butviral DNAcannot bedetected in the healthy seropositive individual. Bone Marrow Transplant 2006; 37: 1051-1059.